PeptideStack
5.2kquestions
20kanswers
220users

How do I compute the +5 charge state m/z for a peptide of 4731.3 Da?

Asked 20 Jan 2025Modified 15 months agoViewed 9k times
5

Concretely: +5 · 4731.3 Da.

Please show the division. I want to check my own against yours.

I would like the general form as well as the specific number, so I can apply it again.

Is my approach right even if my number is wrong?

mass-spec
mass-spec

Mass spectrometry for identity confirmation: electrospray ionisation, multiple charge states, monoisotopic versus average mass, deconvolution, and…

52 questions
dosing-math
dosing-math

The arithmetic itself: milligrams to millilitres to insulin units, concentration after reconstitution, dose per draw, and vial-days per vial. Show…

764 questions
purity
purity

Purity as chromatographic area per cent - the fraction of detected material that is your target peak. It says nothing about how much material is…

833 questions
shareeditfollowflag
BA
askedben_akintola10k1620 Jan 2025

5 Answers

Sorted by votes
83

m/z = 947.27 at 5+. Electrospray charges a peptide by adding protons, so the observed ion is the neutral mass plus 5 protons, all divided by the charge: (4731.3 + 5 × 1.00728) ÷ 5 = 4736.336 ÷ 5 = 947.27. The proton term is the one people drop, and because it is z protons over z charges it shifts m/z by 1.007 at every charge state — small, and far larger than the mass accuracy of the instrument. The neighbouring charge state sits at 789.56, and seeing the two of them where they belong is better identity evidence than either one alone. Use the average mass against an average-mass calculation and the monoisotopic mass against a monoisotopic one; mixing them costs you a couple of daltons on a peptide this size.

A mass shift of exactly zero with a shifted retention time points to an isomer — a scrambled disulfide or a racemised residue — which mass spectrometry alone cannot identify.

A mass shift of plus one usually means deamidation at asparagine or glutamine, which creates a secondary amine instead of an amide and changes the mass by exactly one.

Worth being precise here: a monoisotopic mass includes only the lightest isotope of each element, while the average mass weights by natural isotope abundance, and small peptides use monoisotopic mass.

A correct mass is necessary for identity but not sufficient — you also need the chromatography to confirm it.

shareimprove this answerflag
M4
answeredmz_4113101k35825 Mar 2025
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results
54

Specifically, identity confirmation from mass spectrometry means matching the observed m/z to the calculated m/z for your peptide at its known charge states.

The baseline noise on a mass spectrum sets the limit of detection, and a weak signal close to the noise is not reliable evidence for the presence of a species.

On the detail: a mass shift of minus one hundred and twenty-eight usually means a missing Gln or Lys residue from a synthesis deletion sequence.

Peptide mapping — enzymatic digestion followed by tandem mass spectrometry — can confirm the primary sequence and is the method of choice when identity is ambiguous.

Always run a blank between samples and check for carry-over.

shareimprove this answerflag
KA
answeredkwn_analytical147k3585 Apr 2025
2Thank you — this is the answer I was looking for. – Dr_Priya_Raghunathan 7 months ago
add a comment
40

Stated carefully, the single most important fact about mass spectrometry for peptides is that it measures only the molecular weight and tells you almost nothing about whether the peak is actually your target.

A mass shift of minus eighteen usually means dehydration or a succinimide intermediate, which is pH-dependent and can be reversible.

High-resolution mass spectrometry can distinguish a Lys-containing peptide from an Arg-containing peptide of similar mass because of the isotope difference.

The practical summary: use mass spectrometry for identity, not for purity.

shareimprove this answerflag
OF
answeredorla_ferriter89k1483 Mar 2025
32

Start from what electrospray ionisation does: it ionises the peptide without fragmenting it, creating singly or multiply charged species that the mass analyser then separates by their mass-to-charge ratio.

A mass shift of plus sixteen usually means oxidation at methionine or tryptophan, which is common in peptides and often comes from sample handling rather than synthesis failure.

False positives from contamination are common in mass spectrometry work, and running a blank between every sample and a solvent background are standard practice.

One qualification: high-resolution mass spectrometry gives high mass accuracy but low speed, and the reverse is true for low-resolution instruments.

If you only pay for one test, pay for quantified content. Purity is the number everyone quotes and content is the number that changes what you do.

edited 22 Mar 2025 by RP_C18 — tightened the wording; no substantive change

shareimprove this answerflag
RC
answeredRP_C18105k34814 Mar 2025
26

In practice, tandem mass spectrometry fragments the ions and measures the fragment masses, which provides sequence information and is the best tool for confirming identity.

For a large peptide with multiple peaks in the mass spectrum, comparing the observed isotope pattern to the calculated pattern is a quick check that the formula matches.

Electrospray ionisation soft-ionisation behaviour is well-characterised and standards exist for m/z calibration and mass accuracy assessment.

In practice: ask for the chromatogram, check the method section, check the lot number against the vial, and set your accept threshold before you see the result rather than after.

shareimprove this answerflag
EL
answeredesben_lykke84k1588 May 2025

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.